PHARMALINE
Board
1 director, last change in 2023Director (not named in the articles)
appointed by deed of 06-12-2023
term without a fixed end
earlier manager, until 06-12-2023
listed in the 2024 annual accounts, filed on 31-07-2025
Mandates through the years
1 name, the dashed line is todayFrançois STEEMAN
Director (not named in the articles)
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
- François STEEMAN
- Director (not named in the articles), appointed by deed of 06-12-2023, still in office
- Manager, until 06-12-2023
Control
100%
This company
PHARMALINE
Equity €6,388
Profit €48,353 in 2025
Further up the chainCompagnie de la Chapelle sprl consolidates
Capital
- Contribution
- €6,200
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- COFRANIS
- COMPAGNIE DE LA CHAPELLE
Source: lists of holdings in the owners' accounts
Articles of association
deed of 06-12-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of May at 19:00
Shareholders
2 ownersOwners 2
- COFRANISparentEquity €976,296 Profit of €324,336 in 2025 (profit of €245,547 in 2024)100%
- Compagnie de la Chapelle sprlconsolidating parentconsolidates
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 18-06-2026 ↗
- COFRANIS (BE 0827.642.404) all shares
Capital over time
- 06-12-2023 Converted to unavailable equity · €8,059